BVF GP HOLDINGS LLC's Net Worth

Estimate Recalculated Feb 10, 2025 11:26PM EST

Who is BVF GP HOLDINGS LLC

BVF GP HOLDINGS LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Therapeutics Inc., XOMA Corp, Cullinan Oncology, Inc., Merus N.V., Repare Therapeutics Inc., Verastem, Inc., CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, Principia Biopharma Inc., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., PIERIS PHARMACEUTICALS, INC., Third Harmonic Bio, Inc., FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., enGene Holdings Inc., POINT Biopharma Global Inc., GLYCOMIMETICS INC, and INFINITY PHARMACEUTICALS, INC..

SEC CIK

BVF GP HOLDINGS LLC's CIK is 0001803809

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allakos Inc.

Investor

Updated Jan 26, 2024


Form 4	-100.00%	-8.63M	—	—	Jan 29, 2024	—	Disposition	—	Jan 25 - Jan 26
Form 4	47.80%	1.71M	$5.83	$9.97M	Nov 10, 2022	8.60M	Purchase	—	Nov 08
Form 4	20.43%	557.73K	$12.00	$6.69M	Jan 10, 2022	6.87M	Purchase	—	Jan 06 - Jan 07
Form 4	0.41%	11.03K	$13.94	$153.83K	Sep 23, 2021	6.31M	Purchase	—	Sep 21
Form 4	16.86%	392.27K	$16.49	$6.47M	Sep 15, 2021	6.30M	Purchase	—	Sep 13
Form 4	33.73%	587.00K	$15.47	$9.08M	Jul 06, 2021	5.91M	Purchase	—	Jul 01 - Jul 06
Form 4	7.63%	123.35K	$15.94	$1.97M	May 25, 2021	5.32M	Purchase	—	May 21 - May 24
Form 4	14.80%	208.47K	$16.59	$3.46M	May 20, 2021	5.20M	Purchase	—	May 18 - May 19
Form 4	4.30%	58.00K	$14.26	$827.17K	May 17, 2021	4.99M	Purchase	—	May 13
Form 4/A	522.18%	1.13M	$16.86	$19.10M	May 17, 2021	1.35M	Purchase	—	Apr 23 - Apr 26
Form 4	29.86%	1.13M	$16.86	—	Apr 27, 2021	4.93M	Options	—	Apr 23 - Apr 26
Form 3	—	—	—	—	Apr 27, 2021	—	—	—	—


Form 4	-77.67%	-5.76M	—	—	Jan 19, 2023	1.66M	Disposition	—	Jan 19
Form 4	11.27%	751.40K	$11.00	$8.26M	Jun 03, 2022	7.42M	Purchase	—	Jun 01
Form 4	19.98%	1.11M	$9.09	$10.06M	May 16, 2022	6.66M	Purchase	—	May 12 - May 13
Form 4	5.55%	276.00K	$10.75	$2.97M	Apr 05, 2022	5.55M	Purchase	—	Apr 01
Form 3	—	—	—	—	Jan 10, 2022	5.28M	—	—	—


Form 4	6.52%	1.23M	$5.19	$6.25M	Nov 17, 2023	20.04M	Purchase	—	Nov 15 - Nov 16
Form 4	9.61%	783.71K	$3.60	$2.82M	Nov 03, 2023	8.94M	Purchase	—	Nov 02
Form 4	1.86%	149.16K	$12.73	$1.90M	Jun 15, 2022	8.16M	Purchase	—	Jun 13
Form 4	29.77%	1.84M	$11.90	$21.86M	Jun 06, 2022	8.01M	Purchase	—	Jun 02 - Jun 06
Form 4	7.30%	420.00K	$8.50	$3.57M	May 20, 2022	6.17M	Purchase	—	May 18
Form 4	21.00%	997.96K	$14.10	$14.07M	Jan 21, 2022	5.75M	Purchase	—	Jan 19
Form 3	—	—	—	—	Nov 08, 2021	4.75M	—	—	—


Form 4	-1.49%	-46.41K	$18.00	-$835.36K	Feb 04, 2021	3.06M	Sale	—	Feb 02
Form 4	0.08%	2.53K	$13.32	$33.70K	Jul 02, 2020	3.11M	Purchase	—	Jun 30
Form 4	1.94%	118.00K	$14.16	$1.69M	Jun 22, 2020	6.19M	Purchase	—	Jun 19 - Jun 22
Form 3	—	—	—	—	Jun 22, 2020	2.99M	—	—	—


Form 4	-5.77%	-430.95K	$18.00	-$7.76M	Dec 11, 2020	7.03M	Sale	—	Dec 09
Form 3	—	—	—	—	Dec 04, 2020	7.47M	—	—	—
Form 4	-100.00%	-1.38K	—	—	Nov 20, 2020	7.07M	Disposition	—	Nov 20
Form 3	—	—	—	—	Nov 16, 2020	7.07M	—	—	—


Form 4	—	358.29K	$40.75	$14.60M	Aug 22, 2024	6.49M	Purchase	—	Aug 20
Form 4	—	16.00K	—	—	Jun 28, 2024	6.13M	Grant	—	Jun 18
Form 4	—	979.01K	$25.25	$24.72M	Jan 09, 2024	6.12M	Purchase	—	Jan 05
Form 4	4.36%	414.11K	$12.85	$5.30M	Nov 06, 2023	10.00M	Purchase	—	Nov 02 - Nov 03
Form 4	—	12.00K	—	—	Jun 20, 2023	4.72M	Grant	—	Jun 15
Form 4	0.47%	41.01K	$30.57	$1.25M	Jan 13, 2023	9.08M	Purchase	—	Jan 11 - Jan 12
Form 4	13.46%	545.52K	$26.00	$14.18M	Aug 23, 2022	4.67M	Purchase	—	Aug 22
Form 4	—	12.00K	—	—	Jun 17, 2022	4.13M	Grant	—	Jun 15
Form 4	7.69%	289.43K	$14.34	$4.15M	May 31, 2022	4.11M	Purchase	—	May 26 - May 27
Form 4	0.27%	10.10K	$14.00	$141.39K	May 24, 2022	3.83M	Purchase	—	May 20
Form 4	7.13%	250.00K	$19.45	$4.87M	May 09, 2022	3.81M	Purchase	—	May 05 - May 06
Form 4	4.12%	130.31K	$38.96	$5.08M	Jan 31, 2022	3.56M	Purchase	—	Jan 27 - Jan 31
Form 4	9.43%	272.77K	$37.76	$10.30M	Jan 26, 2022	3.43M	Purchase	—	Jan 24
Form 4	21.28%	544.17K	$47.00	$25.58M	Jul 06, 2021	3.16M	Purchase	—	Jul 01
Form 4	—	20.06K	—	—	Jun 21, 2021	2.62M	Grant	—	Jun 16
Form 4	-0.03%	-661.00	$20.00	—	Aug 25, 2020	2.60M	Options	—	Aug 20 - Aug 21
Form 3	—	—	—	—	Aug 25, 2020	—	—	—	—


Form 4	-22.78%	-1.13M	$27.56	-$31.22M	Oct 08, 2021	3.84M	Sale	—	Oct 07 - Oct 08
Form 4	-30.54%	-2.19M	$20.75	-$45.36M	Jul 07, 2021	4.97M	Sale	—	Jul 02
Form 4	4.37%	300.00K	$19.75	$5.93M	Apr 01, 2021	7.16M	Purchase	—	Mar 30
Form 4	1.99%	79.50K	$22.75	$1.81M	Mar 24, 2021	6.86M	Purchase	—	Mar 22
Form 4	3.83%	250.00K	$23.00	$5.75M	Mar 18, 2021	6.78M	Purchase	—	Mar 16
Form 4	14.86%	844.68K	$24.75	$20.91M	Jan 25, 2021	6.53M	Purchase	—	Jan 21
Form 4	3.11%	160.00K	$16.05	$2.57M	Dec 22, 2020	5.68M	Purchase	—	Dec 18
Form 4	2.73%	146.75K	$11.75	$1.72M	Sep 17, 2020	5.52M	Purchase	—	Sep 15
Form 4	3.66%	189.65K	$11.10	$2.10M	Sep 14, 2020	5.38M	Purchase	—	Sep 10
Form 4	4.05%	201.91K	$11.17	$2.26M	Sep 08, 2020	5.19M	Purchase	—	Sep 03
Form 4	1.78%	87.25K	$15.20	$1.33M	Jun 10, 2020	4.99M	Purchase	—	Jun 08
Form 4	42.57%	1.46M	$14.00	$20.48M	Jun 03, 2020	4.90M	Purchase	—	Jun 01
Form 3	—	—	—	—	Jun 03, 2020	3.19M	—	—	—


Form 4	—	—	—	—	Feb 18, 2021	5.47M	—	—	—
Form 3	—	—	—	—	Dec 28, 2020	5.47M	—	—	—


Form 4	—	7.69K	—	—	Jun 10, 2024	21.71M	Grant	—	Jun 06
Form 4	—	11.30K	—	—	Jun 12, 2023	21.70M	Grant	—	Jun 08
Form 3	—	—	—	—	Apr 15, 2022	21.69M	—	—	—


Form 4	4.63%	2.27K	$35.79	$81.17K	Aug 20, 2020	51.20K	Purchase	—	Aug 18
Form 3	—	—	—	—	Aug 20, 2020	—	—	—	—


Form 4	48.84%	4.75M	$3.65	$17.35M	Oct 31, 2024	27.25M	Purchase	—	Oct 29
Form 4	183.29%	7.86M	—	—	May 13, 2024	22.50M	Purchase	—	May 09
Form 4	500.86%	11.57M	—	—	May 09, 2023	14.64M	Purchase	—	May 05
Form 3	—	—	—	—	Jan 31, 2022	2.31M	—	—	—
Form 4	401.10%	1.27M	—	—	Dec 28, 2020	1.74M	Options	—	Dec 22
Form 3	—	—	—	—	Oct 05, 2020	193.93K	—	—	—


Form 4	—	23.00K	—	—	Jun 18, 2024	9.05M	Grant	—	Jun 14
Form 4	22.02%	1.61M	$9.84	$14.82M	Sep 14, 2023	9.03M	Purchase	—	Sep 12 - Sep 14
Form 4	—	21.52K	—	—	Jun 21, 2023	7.42M	Grant	—	Jun 16
Form 4	3.02%	200.00K	$4.03	$806.90K	Jun 14, 2022	7.38M	Purchase	—	Jun 10
Form 4	11.64%	739.67K	$9.39	$6.95M	Dec 02, 2021	7.18M	Purchase	—	Nov 30
Form 4	—	99.56K	—	—	May 26, 2021	6.52M	Acq/Dis	—	Mar 31
Form 4	23.00%	1.20M	$19.00	—	Nov 20, 2020	6.42M	Purchase	—	Nov 18 - Nov 19
Form 3	—	—	—	—	Nov 19, 2020	—	—	—	—


Form 4	—	10.97K	—	—	May 19, 2023	3.91M	Grant	—	May 17
Form 4	0.66%	22.25K	$19.15	$420.74K	Jan 09, 2023	3.90M	Purchase	—	Jan 05 - Jan 06
Form 4	0.73%	24.64K	$16.61	$409.31K	Sep 27, 2022	3.88M	Purchase	—	Sep 23 - Sep 27
Form 4	1.70%	56.31K	$17.70	$990.72K	Sep 16, 2022	3.85M	Purchase	—	Sep 14 - Sep 16
Form 4	—	9.00K	—	—	May 20, 2022	3.80M	Grant	—	May 18
Form 4	—	5.10K	—	—	May 21, 2021	3.79M	Grant	—	May 19
Form 4	-15.58%	-651.70K	$38.36	-$25.00M	Apr 02, 2021	3.78M	Sale	—	Mar 31
Form 4	—	200.00K	$25.00	$5.00M	Dec 15, 2020	4.43M	Purchase	—	Dec 11
Form 4	1.37%	51.37K	$18.34	$941.96K	Sep 23, 2020	4.23M	Purchase	—	Sep 21 - Sep 23
Form 4	0.21%	7.74K	$18.77	$145.23K	Sep 10, 2020	4.18M	Purchase	—	Sep 04
Form 4	0.96%	35.62K	$18.71	$666.48K	Sep 01, 2020	4.16M	Purchase	—	Aug 28 - Sep 01
Form 4	0.77%	28.18K	$19.41	$546.65K	Aug 25, 2020	4.13M	Purchase	—	Aug 21 - Aug 25
Form 4	0.31%	6.16K	$19.47	$120.00K	Aug 20, 2020	4.06M	Purchase	—	Aug 18 - Aug 20
Form 4	1.40%	27.02K	$18.46	$498.74K	Aug 14, 2020	4.06M	Purchase	—	Aug 12 - Aug 14
Form 4	52.51%	1.25M	$13.00	$16.29M	Apr 17, 2020	4.03M	Options	—	Apr 15
Form 4	0.65%	8.26K	$17.20	$142.13K	Mar 27, 2020	2.78M	Purchase	—	Mar 25
Form 4	0.35%	4.44K	$14.52	$64.47K	Mar 20, 2020	2.77M	Purchase	—	Mar 18
Form 4	10.31%	118.28K	$17.94	$2.12M	Mar 17, 2020	2.77M	Purchase	—	Mar 13 - Mar 17
Form 3	—	—	—	—	Mar 17, 2020	2.25M	—	—	—


Form 4	-100.00%	-9.33M	$9.10	-$80.59M	Jun 28, 2023	—	Disposition	—	Jun 26
Form 4	—	80.00K	—	—	Apr 07, 2023	9.33M	Grant	—	Apr 05
Form 4	-1.45%	-129.24K	$6.12	-$52.02M	Aug 11, 2022	9.25M	Sale	—	Aug 09
Form 4	—	80.00K	—	—	Mar 11, 2022	9.38M	Grant	—	Mar 09
Form 4	35.51%	2.00M	$275.90	$5.08M	Apr 05, 2021	9.30M	Purchase	—	Apr 01
Form 4	—	80.00K	—	—	Mar 12, 2021	7.30M	Grant	—	Mar 10
Form 4	85.30%	1.92K	—	—	Mar 04, 2020	6.95M	Purchase	—	Mar 02 - Mar 04
Form 3	—	—	—	—	Mar 04, 2020	5.15M	—	—	—


Form 3	—	—	—	—	Aug 01, 2024	7.26M	—	—	—
Form 3	—	—	—	—	Jun 27, 2022	3.91M	—	—	—


Form 4	-23.05%	-1.00M	$14.30	-$14.30M	Oct 31, 2024	3.34M	Sale	—	Oct 29
Form 4	5.19%	214.06K	$4.11	$879.50K	Dec 22, 2022	4.34M	Purchase	—	Dec 20
Form 3	—	—	—	—	Dec 22, 2022	4.12M	—	—	—


Form 3	—	—	—	—	Mar 08, 2021	6.26M	—	—	—
Form 4	-85.66%	-7.39M	$20.19	-$149.25M	Nov 13, 2020	1.24M	Sale	—	Nov 11
Form 4	5.46%	446.56K	$4.89	$2.18M	Nov 06, 2020	8.63M	Purchase	—	Nov 04 - Nov 06
Form 4	4.40%	345.24K	$5.04	$1.74M	Oct 08, 2020	8.18M	Purchase	—	Oct 06
Form 4	0.01%	32.00	$3.80	$121.56	Sep 24, 2020	7.84M	Purchase	—	Sep 22
Form 4	3.89%	293.59K	$4.10	$1.20M	May 18, 2020	7.84M	Purchase	—	May 14
Form 3	—	—	—	—	May 18, 2020	7.01M	—	—	—


Form 4	—	—	—	—	May 12, 2023	12.58M	Acq/Dis	—	May 10
Form 3	—	—	—	—	Feb 13, 2023	12.58M	—	—	—


Form 4	-100.00%	-17.16M	$12.45	-$213.66M	Dec 20, 2023	—	Sale	—	Dec 18
Form 3	—	—	—	—	Nov 06, 2023	17.16M	—	—	—


Form 4	15.72%	1.27M	$2.60	$3.29M	Nov 06, 2020	9.32M	Purchase	—	Nov 04
Form 4	13.09%	932.61K	$2.75	$2.56M	Nov 03, 2020	8.06M	Purchase	—	Oct 30

BVF GP HOLDINGS LLC's Net Worth

Who is BVF GP HOLDINGS LLC

SEC CIK

Past Insider Trading and Trends

Allakos Inc.

Rain Oncology Inc.

Cullinan Oncology, Inc.

Repare Therapeutics Inc.

Verastem, Inc.

IDEAYA Biosciences, Inc.

CYTOKINETICS INC

Kymera Therapeutics, Inc.

Merus N.V.

CytomX Therapeutics, Inc.

MoonLake Immunotherapeutics

Principia Biopharma Inc.

Eledon Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

XOMA Corp

CTI BIOPHARMA CORP

ESSA Pharma Inc.

4D Molecular Therapeutics, Inc.

PIERIS PHARMACEUTICALS, INC.

Third Harmonic Bio, Inc.

FIVE PRIME THERAPEUTICS, INC.

Structure Therapeutics Inc.

enGene Holdings Inc.

POINT Biopharma Global Inc.

GLYCOMIMETICS INC

INFINITY PHARMACEUTICALS, INC.


Form 4	—	—	—	—	Feb 19, 2021	8.26M	—	—	—
Form 4	-21.48%	-2.26M	$5.37	-$12.13M	Feb 16, 2021	8.26M	Sale	—	Feb 11
Form 4	-35.72%	-5.85M	$4.14	-$24.21M	Jan 26, 2021	10.52M	Sale	—	Jan 22